It is an inevitability that the body will eventually break down. Of course, it is of paramount importance to care for our health, however, eventually fractures, disease, or simply the aging process cause bones to break. When this does occur, it is vital to be able to replace or reconstruct these bones. As medical sciences have advanced, scientists have discovered a number of viable substitutes for bone material that work well. In the future, however, it appears as though the regeneration of bone material will take a more dominant role. At its current rate, the artificial bone market is expanding at 7 – 8% per annum, and its volume is around the 9 billion USD mark. European, and in particular French manufacturers such as Biomatlante and Graftys control the stranglehold of this share. However, Korea’s leading artificial bone substitute manufacture is poised to elevate into the discussion.
Since the company’s inception in 1991, Kyungwon Medical has been working diligently on developing artificial bone substitutes, bone cements, bone cement injection needles, osteoporosis controlled needles, as well as other related technologies. As well as a dedication to technological improvement, the company is also dedicated to the concept of “enhancing the gift of life” by providing patients with products that will improve their overall quality of life, as well as making life easier on the surgeons who are performing these vital surgeries.
PolyBone is a revolutionary bone substitute that is composed of B-TCP that supports bone growth and polyphosphate that accelerates bone reconstruction. PolyBone contains a microporous particle that allows the vessel and bone itself to grow easily, making it the most ideal bone material substitute in the world. PolyBone is available in a Powder Type, Granule Type, as well as Block Type. For more information, please visit http://www.kyungwonmedical.com/
KYUNGWON MEDICAL has been selected as the KOTRA Seal of Excellence since 2009
